Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis.

The safety, tolerance, and pharmacokinetics of amphotericin B lipid complex (ABLC) were studied in a cohort of pediatric cancer patients. Six children with hepatosplenic candidiasis (HSC) received 2.5 mg of ABLC/kg of body weight/day for 6 weeks for a total dosage of 105 mg/kg. Mean serum creatinine...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Walsh, T J, Whitcomb, P, Piscitelli, S, Figg, W D, Hill, S, Chanock, S J, Jarosinski, P, Gupta, R, Pizzo, P A
Format: Artigo
Langue:Inglês
Publié: 1997
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC164041/
https://ncbi.nlm.nih.gov/pubmed/9303390
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires